Juan Medaura retweetledi

Thanks @asnpublications ASN in the Loop for featuring our study @ASNKidney360 on “Biopsy-proven renal sarcoidosis & outcomes” led by @jingmiao2019 @fervenzafernan1 @LadanZand @MayoClinicNeph
•🧪 Study: 43 patients with biopsy-proven renal sarcoidosis
•🔬 Findings:
•84% interstitial nephritis
•33% granulomatous interstitial nephritis
•⏱️ Recovery (6 months):
•74% complete ✅
•12% partial 🔄
•Total recovery: 86%
•⚠️ Long-term adverse outcomes: 40%
•📉 Risk factors:
•Higher serum creatinine at biopsy 🩸
•Interstitial fibrosis & tubular atrophy 🧫
•Pre-existing CKD 🩺
•💊 Steroids: Lower risk of long-term adverse outcomes 👍
journals.lww.com/kidney360/abst…


English





















